KOR

e-Article

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably with those in DLBCL: a GLA/DRST registry study
Document Type
Short Communication
Source
In Blood Advances 24 October 2023 7(20):6191-6195
Subject
Lymphoid Neoplasia
Immunobiology and Immunotherapy
Language
ISSN
2473-9529